Precision Medicine Meets Brain Health Webinar
Precision Medicine Meets Brain Health: Why Sex and Gender Matter? Webinar 27 June, 2025 A great turnout at our 26 June webinar “Precision Medicine Meets Brain Health: Why Sex and Gender Matter” – thank you for joining us! We are immensely grateful to everyone who attended our webinar and supported this meaningful conversation. A heartfelt thank […]
Menopause at your work in Switzerland
Your Voice Matters: Let’s Talk Menopause at Work! 26 June, 2025 Are you a working woman navigating the challenges of perimenopause or menopause? You’re not alone—and your experience matters. From brain fog to sleep issues, hot flashes to mood changes, many women face real symptoms that can impact their careers. Yet too often, the conversation […]
Award winning media article
Award winning media article inspired by the work of the Women’s Brain Foundation 17 June, 2025 Jessica Davis Pluess, alongside her colleague Pauline Turuban, recently earned second place in the pharma strategy and innovation category of the prestigious Semmelweis-Richter Health Journalism Award. Their awarded article, “Drugmakers Are Finally Making Medicine for Women,” was written in […]
A Powerful Collaboration for Brain Health and Longevity
A Powerful Collaboration for Brain Health and Longevity 10 June, 2025 We are thrilled to announce our strategic partnership with the prestigious St. Moritz Longevity Forum—an annual gathering that brings together world-leading experts and distinguished attendees in the breathtaking surroundings of St. Moritz, globally celebrated as a premier luxury destination. As thought leaders in precision […]
Latest Systematic Review
Sex and gender differences in access, quality of care, and effectiveness of treatment in dementia: a scoping review of studies up to 2024 06 June, 2025 This scoping review aimed to summarize the evidence on sex and gender differences in access to treatment, quality of care, and treatment effectiveness for people with dementia. The review […]
The Economist | Alzheimer’s drug pipeline healthier than you might think
World Health Organisation General Assembly 05 June, 2025 We were featured in The Economist article on the shifting landscape of Alzheimer’s drug development. After decades of limited progress, a new generation of Alzheimer’s therapies is finally emerging—targeting not just amyloid, but also tau, neuroinflammation, metabolic dysfunction, vascular health, and even sleep regulation. A full review […]
World Health Organisation 78th General Assembly
World Health Organisation General Assembly 05 June, 2025 During the 78th GA of the WHO, while strengthening collaboration with our partners and presenting our findings on the economic return derived from investment on the Women’s Brain Capital, we participated in a high-level roundtable hosted by Foreign Policy and Takeda to discuss funding for non communicable […]
WBF Supports Global Advocacy to Include Neurology in NCD Commitments
WBF Supports Global Advocacy to Include Neurology in NCD Commitments 05 June, 2025 In alignment with our mission to advance equitable brain health, the Women’s Brain Foundation contributed to the OneNeurology initiative and the NCD Alliance’s response to the UN Zero Draft Political Declaration ahead of the 4th High-Level Meeting on Non-Communicable Diseases. The recommendations […]
World Multiple Sclerosis Day
World Multiple Sclerosis Day 05 June, 2025 World Multiple Sclerosis Day was observed on May 30. It’s a day in the year dedicated to raising awareness about Multiple Sclerosis (MS) a chronic neurological condition that affects the nervous system disrupting communication between the brain and the rest of the body. It disproportionately impacts women, with studies […]
Prescription for Change: Policy Recommendations for Women’s Health Research.
Prescription for Change: Policy Recommendations for Women’s Health Research Zurich, Switzerland | 22 May, 2025 | BY: WEF Global Women’s Alliance for Health Women are half the population yet health issues that affect them exclusively, differently or disproportionately remain under-researched and under-funded. For example, just 7% of healthcare research targets conditions that exclusively affect women. […]
